Subsequent studies demonstrated the detection of a chimeric mRNA resulting from the fusion of the two genes, BCR and ABL1, in patients with CML [11,12]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.